Blair William & CO Teva Pharmaceutical Industries LTD Transaction History

Blair William & CO

$32 Billion
Q2 2024

A detailed history of Blair William & CO transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Blair William & CO holds 10,505 shares of TEVA stock, worth $183,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,505

Previous 10,387 1.14%

Holding current value

$183,732

Previous $146,000 16.44%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$12.78 - $17.4 $1,508 - $2,053	118 Added 1.14%	10,505 $170,000
Q1 2024 May 09, 2024	SELL	$10.67 - $14.43 $778 - $1,053	-73 Reduced 0.7%	10,387 $146,000
Q4 2023 Feb 12, 2024	SELL	$8.12 - $10.63 $3,572 - $4,677	-440 Reduced 4.04%	10,460 $109,000
Q3 2023 Nov 09, 2023	BUY	$7.48 - $10.7 $972 - $1,391	130 Added 1.21%	10,900 $111,000
Q2 2023 Aug 11, 2023	SELL	$7.2 - $9.47 $129 - $170	-18 Reduced 0.17%	10,770 $81,000
Q1 2023 May 12, 2023	BUY	$8.36 - $11.37 $317 - $432	38 Added 0.35%	10,788 $95,000
Q4 2022 Feb 10, 2023	SELL	$7.95 - $9.48 $2,385 - $2,844	-300 Reduced 2.71%	10,750 $98,000
Q3 2022 Nov 09, 2022	SELL	$6.86 - $11.95 $25,039 - $43,617	-3,650 Reduced 24.83%	11,050 $89,000
Q1 2022 May 13, 2022	SELL	$7.33 - $9.39 $17,460 - $22,366	-2,382 Reduced 13.94%	14,700 $138,000
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $10,017 - $12,920	-1,268 Reduced 6.91%	17,082 $137,000
Q2 2021 Aug 12, 2021	SELL	$9.9 - $11.56 $4,950 - $5,780	-500 Reduced 2.65%	18,350 $182,000
Q1 2021 May 13, 2021	SELL	$10.34 - $12.81 $8,664 - $10,734	-838 Reduced 4.26%	18,850 $218,000
Q4 2020 Feb 09, 2021	SELL	$8.61 - $11.04 $213,760 - $274,090	-24,827 Reduced 55.77%	19,688 $190,000
Q3 2020 Nov 06, 2020	SELL	$8.57 - $12.69 $16,711 - $24,745	-1,950 Reduced 4.2%	44,515 $401,000
Q2 2020 Aug 12, 2020	SELL	$8.12 - $13.12 $1,477 - $2,387	-182 Reduced 0.39%	46,465 $573,000
Q1 2020 May 11, 2020	BUY	$6.69 - $13.45 $9,907 - $19,919	1,481 Added 3.28%	46,647 $419,000
Q4 2019 Feb 13, 2020	BUY	$6.53 - $10.72 $294,933 - $484,179	45,166 New	45,166 $443,000
Q2 2019 Aug 13, 2019	SELL	$8.12 - $15.72 $775,118 - $1.5 Million	-95,458 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $341,871 - $439,079	-21,943 Reduced 18.69%	95,458 $1.5 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $303,997 - $496,730	20,836 Added 21.58%	117,401 $1.81 Million
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $783,747 - $954,564	37,215 Added 62.7%	96,565 $2.08 Million
Q2 2018 Aug 13, 2018	SELL	$16.77 - $24.71 $114,723 - $169,041	-6,841 Reduced 10.34%	59,350 $1.44 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $16,446 - $21,761	-986 Reduced 1.47%	66,191 $1.13 Million
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $119,329 - $202,956	-10,626 Reduced 13.66%	67,177 $1.27 Million
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $1.2 Million - $2.5 Million	77,803	77,803 $1.37 Million

Others Institutions Holding TEVA

# of Institutions

604

Shares Held

567M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account